Social Media Ideas for Fda Advisory Committee

FDA advisory committee for peptides stocked with conflicts of interest

The FDA has listed its advisory members for the committee that will discuss peptides in late July.Owais Durrani, DO, an emergency medicine physician in Houston, previously wrote fo...

<![CDATA[FDA Advisory Panel to Vote on Composition of Covid-19 Vaccines for 2026-2027 ]]>

<![CDATA[FDA Advisory Committee Votes Unanimously in Favor of the Benefit-Risk Profile of mRNA-1010 ]]>

FDA Scientists Warn Against Expanded Peptide Access As Kennedy Reshapes Advisory Panel

WEDNESDAY, July 1, 2026 — Federal health scientists are urging caution about expanding access to controversial peptide drugs, even as the U.S. Food and Drug Administration (FDA) re...

FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr.

The Food and Drug Administration is meeting next month to consider easing restrictions on several peptides, a group of unapproved drugs popular with followers of Robert F. Kennedy...

<![CDATA[Pharmaceutical Executive Daily: FDA Advisory Committee Votes Unanimously in Favor of The Benefit-Risk Profil...

FDA delays ruling on AstraZeneca’s breast cancer drug after negative adcomm vote

The FDA has delayed a decision on the approval of AstraZeneca’s camizestrant, deferring its ruling to review analyses filed after an advisory committee voted against the breast can...

At first public hearing for FDA’s CNPV program, industry support meets ‘deep concern’ from experts

On Thursday, the public had the first chance to air their grievances about the FDA’s controversial Commissioner’s National Priority Voucher (CNPV) pilot program, the flagship initi...

Moderna flu vaccine wins unanimous support from FDA panel

The endorsement of an advisory committee positions Moderna to complete a dramatic turnaround for a shot the FDA declined to review earlier this year.

Key FDA committee unanimously recommends its first vaccine since 2023

All nine members of the committee unanimously voted to recommend Moderna's new mRNA influenza vaccine for adults 50 and over.

On second try, Acadia drug gets nod from European regulators

The influential CHMP committee also threw its support behind more than a dozen other medicines while recommending the marketing authorization for Tavneos be revoked.

FDA staff scrutinizes evidence supporting Moderna’s flu vaccine

Ahead of a Thursday advisory panel meeting, agency scientists highlighted shortcomings in data accrued for a vaccine the FDA controversially refused to even review earlier this yea...

Moderna Announces FDA Advisory Committee Votes Unanimously in Favor of the Benefit-Risk Profile of mRNA-1010, an Investi...

FDA Prescription Drug User Fee Act (PDUFA) goal date remains August 5, 2026

From Caffeine To 'Healthy' Labeling, FDA Sets Year-End Agenda For US Food Supply

TUESDAY, June 30, 2026 — The U.S. Food and Drug Administration (FDA) has announced the food supply issues it seeks to tackle by year’s end. The FDA’s Human Food Program aims to pre...

Praxis faces FDA decision delay as analysts point finger at agency layoffs

The FDA has delayed a decision on the approval of Praxis Precision Medicine’s rare epilepsy prospect by three months. TD Cowen analysts said they “strongly believe FDA bandwidth co...

FDA Issues Draft Guidance Clarifying Use of Form FDA 3542

FDA committee unanimously recommends first mRNA flu vaccine

The Food and Drug Administration's top vaccine advisory committee voted Thursday to recommend an mRNA influenza vaccine. It's the first flu vaccine that uses the same technology as...

<![CDATA[FDA Sends CRL to Cingulate for CTx-1301]]>

FDA scientists flag concerns with peptides, the trendy molecules RFK Jr. supports

Documents reviewing the research on peptides note lack of good evidence of efficacy or safety. Yet an FDA panel will consider easing access to them later this month.

FDA Supports Grouping Several Phthalates for Cumulative Risk Assessment

FDA published a literature review on the eight phthalates currently approved for food contact uses to determine whether they should be considered chemically and/or pharmacologicall...

FDA delays decision on AstraZeneca breast cancer pill

The review extension comes weeks after an advisory panel found the evidence supporting the drug, camizestrant, inconclusive in what would be a new kind of treatment setting.

RFK Jr. stacks FDA panel with peptide peddlers as FDA scientists oppose access

Peptide drugs are popular, but FDA scientists warn they're untested, may be harmful.

FDA’s Human Foods Program Releases Updated 2026 Guidance Agenda

FDA halts release of new drug rejection letters while working to formalize policy

The FDA has paused a controversial policy of releasing letters describing its rationale for rejecting drugs, Fierce Biotech has learned, following a citizen’s petition from an unna...